Merck & Company (MRK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 14,593,000 | 15,901,000 | 13,521,000 | 13,154,000 | 11,402,000 |
| Cost of Goods | 4,216,000 | 5,380,000 | 3,873,000 | 3,450,000 | 3,104,000 |
| Gross Profit | 10,377,000 | 10,521,000 | 9,648,000 | 9,704,000 | 8,298,000 |
| Operating Expenses | 5,310,000 | 4,899,000 | 5,897,000 | 4,781,000 | 6,602,000 |
| Operating Income | 5,067,000 | 5,622,000 | 3,751,000 | 4,923,000 | 1,696,000 |
| Other Income | -580,000 | -761,000 | 158,000 | 343,000 | 21,000 |
| Pre-tax Income | 4,487,000 | 4,861,000 | 3,909,000 | 5,266,000 | 1,717,000 |
| Income Tax | 538,000 | 554,000 | 85,000 | 695,000 | 503,000 |
| Net Income Continuous | 3,949,000 | 4,307,000 | 3,824,000 | 4,571,000 | 1,214,000 |
| Net Income Discontinuous | N/A | N/A | 372,000 | N/A | 332,000 |
| Minority Interests | 5,000 | -3,000 | 438,000 | 4,000 | 1,000 |
| Net Income | $3,944,000 | $4,310,000 | $3,758,000 | $4,567,000 | $1,545,000 |
| EPS Basic Total Ops | 1.56 | 1.70 | 1.48 | 1.81 | 0.61 |
| EPS Basic Continuous Ops | 1.56 | 1.70 | 1.51 | 1.81 | 0.48 |
| EPS Basic Discontinuous Ops | N/A | N/A | -0.02 | N/A | 0.13 |
| EPS Diluted Total Ops | 1.55 | 1.70 | 1.48 | 1.80 | 0.61 |
| EPS Diluted Continuous Ops | 1.55 | 1.70 | 1.50 | 1.80 | 0.48 |
| EPS Diluted Discontinuous Ops | N/A | N/A | -0.02 | N/A | 0.13 |
| EBITDA(a) | $6,005,000 | $6,742,000 | $4,586,000 | $5,682,000 | $2,424,000 |